G9S (p.Gly9Ser) variant of IDS (Iduronate 2-sulfatase)
G9S (p.Gly9Ser) in IDS (Iduronate 2-sulfatase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data and structural context.
G9S (p.Gly9Ser) variant details
- p.Gly9Ser
- rs1557340605
- gnomAD rs1557340605
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.244
- REVEL 0.35
- CADD 4.88
- PolyPhen-2 0.00
- SIFT 0.40
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 1.2e-06)
- Structural context available